Spero Therapeutics, Inc. Operating Lease Right-of-Use Assets
Spero Therapeutics, Inc. (SPRO) had Operating Lease Right-of-Use Assets of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $1.03M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.26M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.48M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.50M; Operating Lease, Right-of-Use Asset as first filed $1.69M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.26M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.48M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.50M 10-K · filed 2026-03-26 | $1.69M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.56M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.84M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $3.11M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $3.38M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.64M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $3.90M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.16M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $4.40M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.65M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.89M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.12M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $5.36M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.58M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $6.31M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $6.53M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $6.50M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $6.71M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $6.92M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $7.11M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $7.31M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.85M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.76M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $4.88M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $3.94M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $4.19M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.37M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |